SlitLED

Company Overview

Snapshot

Founded in October 2018 by Michael Narodizky and Dr. Benjamin Halevy, SlitLED operates with 1–10 employees. The company has secured funding across two rounds, including a grant from the Israel Innovation Authority in August 2019, demonstrating early institutional support for its innovative medical device.

Business overview

SlitLED develops a commercial slit lamp designed for ophthalmic telemedicine, enabling eye physicians to conduct comprehensive remote slit examinations with full medical efficacy. The company's core technology involves two units: one for the doctor's office and a patient unit for remote clinics or optical stores, allowing real-time control during teleconferences. SlitLED operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Digital Healthcare, serving the North American market with its B2B business model.

Strategic signal

In March 2020, SlitLED's innovative approach to eye care was highlighted by Calcalistech, signaling the company's potential to revolutionize ophthalmic telemedicine. This recognition underscores the market's growing interest in remote diagnostic solutions and validates SlitLED's strategic direction in making specialized eye examinations more accessible.

Company Intelligence Q&A

What is SlitLED's primary product?

SlitLED's primary product is a commercial slit lamp designed for telemedicine, which allows eye physicians to perform comprehensive remote slit examinations.

When was SlitLED founded and by whom?

SlitLED was founded in October 2018 by Michael Narodizky and Dr. Benjamin Halevy.

Has SlitLED received any grants?

Yes, in August 2019, SlitLED secured a grant from the Israel Innovation Authority.

What is the company's business model?

SlitLED operates on a B2B business model, targeting healthcare providers and clinics.

What markets does SlitLED target?

SlitLED primarily targets the North American geomarket for its teleophthalmology solutions.